From:
Mark Bellgrove <xxxx.xxxxxxxxx@xxxxxx.xxx>
Sent:
Friday, 8 April 2022 9:43 PM
To:
Duggan, Geraint
Cc:
Hoffman, Sharon; Clinical Guidelines
Subject:
Re: NHMRC guideline approval [SEC=OFFICIAL]
Many thanks Geraint I understand  
Best 
Mark  
On 8 Apr 2022, at 2:11 pm, Duggan, Geraint <xxxxxxx.xxxxxx@xxxxx.xxx.xx> wrote: 
Hi Mark 
I haven’t forgotten about getting back to you with submission a date. We are still in the process of 
contracting a methodological reviewer so it will be a few weeks yet before that process is finished. 
We are getting some expert reviews coming back to us in the next two weeks so if it would help we 
could consolidate them and send before the methodological review if that would help. I’m sorry it’s 
still unclear at the moment but securing methodological reviewers has been difficult now that so 
many guidelines have re‐emerged after the COVID break. 
Thanks for your understanding 
Geraint 
Geraint Duggan  
Director, Clinical Guidelines 
Research Translation Branch 
National Health and Medical Research Council 
xxxxxxx.xxxxxx@xxxxx.xxx.xx 
+61 3 8866 0403 / 0414 045 550
nhmrc.gov.au
The linked image cannot be  
displayed.  The file may  hav e  
been mov ed, renamed, or  
deleted. Verify that the link  
points to the correct file and  
location.
This email (including any attached files) is intended only for the 
addressee, it may contain confidential information. If you are not the 
addressee, you are notified that any transmission, distribution, printing 
or duplication of this email is strictly prohibited. If you have received 
this email in error please promptly inform the sender and delete all 
copies of this e-mail and all attachments. 
Unless explicitly attributed, the opinions expressed do not necessarily 
represent the official position of the National Health and Medical 
Research Council. 
Please consider the environment before printing this email, thank you. 
1

---